Cerebellar volume as an outcome measure in therapeutic trials of primary progressive multiple sclerosis

被引：0

作者：

Inglese, M. ^{[1
]}

Petracca, M. ^{[1
]}

Saiote, C. ^{[1
]}

Ruggieri, S. ^{[1
]}

Fabian, M. ^{[1
]}

Howard, J. ^{[2
]}

Riley, C. ^{[3
]}

Krieger, S. ^{[1
]}

Miller, A. ^{[1
]}

Lublin, F. ^{[1
]}

Sormani, M. P. ^{[4
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[2] NYU, Langone Med Ctr, New York, NY USA

[3] Columbia Univ, Med Ctr, New York, NY USA

[4] Univ Genoa, Genoa, Italy

来源：

MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P466

引用

页码：198 / 199

页数：2

共 50 条

[21] The natural history of multiple sclerosis: a geographically based study - 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis
Cottrell, DA
Kremenchutzky, M
Rice, GPA
Hader, W
Baskerville, J
Ebers, GC
BRAIN, 1999, 122 : 641 - 647
[22] A case report: a primary progressive multiple sclerosis (PPMS) with adolescent-onset of progressive cerebellar ataxia
Yang, S-K.
Lin, J-J.
MOVEMENT DISORDERS, 2017, 32
[23] Brain atrophy as an outcome measure for multiple sclerosis clinical trials A "no-brainer"?
Rudick, Richard A.
Fisher, Elizabeth
NEUROLOGY, 2009, 72 (07) : 586 - 587
[24] Imaging as an Outcome Measure in Multiple Sclerosis
Daniel Ontaneda
Robert J. Fox
Neurotherapeutics, 2017, 14 : 24 - 34
[25] Imaging as an Outcome Measure in Multiple Sclerosis
Ontaneda, Daniel
Fox, Robert J.
NEUROTHERAPEUTICS, 2017, 14 (01) : 24 - 34
[26] The lymphocyte subpopulation in patients with primary progressive multiple sclerosis and secondary progressive multiple sclerosis
Belniak, Ewa
Bojarska-Junak, Agnieszka
Bartosik-Psujek, Halina
Mitosek-Szewezyk, Krystyna
Kulka, Malgorzata
Stelmasiak, Zbigniew
Rolinski, Jacek
MULTIPLE SCLEROSIS, 2008, 14 : S116 - S116
[27] THERAPEUTIC TRIALS FOR MULTIPLE-SCLEROSIS
MCKHANN, GM
ANNALS OF NEUROLOGY, 1990, 27 (06) : 589 - 590
[28] THERAPEUTIC TRIALS IN MULTIPLE-SCLEROSIS
NOSEWORTHY, JH
SELAND, TP
EBERS, GC
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (03) : 355 - 362
[29] Hydroxychloroquine for Primary Progressive Multiple Sclerosis
Koch, Marcus W.
Kaur, Sharanjit
Sage, Kayla
Kim, Janet
Levesque-Roy, Myriam
Cerchiaro, Graziela
Yong, Voon Wee
Cutter, Gary R.
Metz, Luanne M.
ANNALS OF NEUROLOGY, 2021, 90 (06) : 940 - 948
[30] Diagnosis of primary progressive multiple sclerosis
Montalban, X
NEUROLOGICAL SCIENCES, 2004, 25 : S31 - S31

← 1 2 3 4 5 →